Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease

被引：0
|
作者：
Bloom, JM [1 ]
机构：
[1] Cent Coast Primary Care, San Luis Obispo, CA 93401 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1999年 / 341卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1854 / 1854
页数：1
相关论文
共 50 条
  • [21] Three Decades of Lipid-Lowering Therapy in Type 2 Diabetic Patients with Angiographically Proven Stable Coronary Artery Disease
    Vogel, Johannes
    Ratz, Magdalena
    Elsner, Pascal
    Plattner, Thomas
    Vonbank, Alexander
    Mader, Arthur
    Larcher, Barbara
    Leiherer, Andreas
    Muendlein, Axel
    Frick, Matthias
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2024, 73
  • [22] Bailout inclisiran-based triple lipid-lowering therapy reduces plaque lipid content in stable coronary artery disease patients
    Trusinskis, K.
    Lapsovs, M.
    Kokina, B.
    Karantajere, M.
    Knoka, E.
    Caunite, L.
    Jegere, S.
    Narbute, I.
    Sondore, D.
    Grave, A.
    Kumsars, I.
    Erglis, A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [23] Intensive lipid-lowering therapy in patients with coronary heart disease
    Lauderdale, SA
    Sheehan, AH
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (02) : 329 - 334
  • [24] Lipid-lowering therapy for the primary prevention of coronary heart disease
    Gotto, AM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) : 2078 - 2082
  • [25] Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting
    Lacy, CR
    Swartz, CD
    Moylan, DM
    Bueno, M
    Suh, DC
    Barone, JA
    Kostis, JB
    CIRCULATION, 1998, 98 (17) : 45 - 46
  • [26] Impact of daily glucose fluctuation on progression of luminal narrowing in stable coronary artery disease patients pretreated with lipid-lowering therapy
    Yamamoto, H.
    Shinke, T.
    Otake, H.
    Takaya, T.
    Kuroda, M.
    Takahashi, H.
    Toba, Y.
    Terashita, D.
    Kuroda, K.
    Tahara, N.
    Uzu, K.
    Shinkura, Y.
    Nagasawa, Y.
    Hirata, K.
    EUROPEAN HEART JOURNAL, 2016, 37 : 389 - 389
  • [27] Intensive lipid-lowering therapy in coronary artery disease: implications of the REVERSAL and PROVE-IT trials
    Salam, AM
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (06) : 707 - 713
  • [28] Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting
    Lacy, CR
    Suh, DC
    Barone, JA
    Bueno, M
    Moylan, D
    Swartz, C
    Kudipudi, RV
    Kostis, JB
    ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (04) : 468 - 473
  • [29] Functional improvement in coronary artery disease after 20 months of lipid-lowering therapy with policosanol
    Batista, JF
    Stusser, RJ
    Padron, R
    Sosa, F
    Pereztol, O
    Perez, B
    ADVANCES IN THERAPY, 1996, 13 (03) : 137 - 148
  • [30] Effect of lipid levels and lipid-lowering therapy on Restenosis after coronary artery stenting
    Lerakis, Stamatios
    El-Chami, Mikhael F.
    Patel, Amar D.
    Veledar, Emir
    Alexopoulos, Elias
    Zacharoulis, Achilleas
    Triantafyllou, Aggeliki
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2006, 331 (05): : 270 - 273
12345